Monte Rosa Therapeutics, Inc. (GLUE) Stock Price, News, Quote & History - Yahoo Finance

By Yahoo! Finance | Oct 28, 2024 at 09:05 AM EST

Monte Rosa Therapeutics has signed a deal with Novartis to develop "molecular glue degraders" targeting abnormal proteins in challenging diseases. The agreement includes potential payments of $2.1 billion and royalties on sales outside the U.S.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.